| Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review L Gennari, D Merlotti, V De Paola, A Calabro, L Becherini, G Martini, ... American journal of epidemiology 161 (4), 307-320, 2005 | 346 | 2005 |
| Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure A Palazzuoli, M Gallotta, I Quatrini, R Nuti Vascular health and risk management, 411-418, 2010 | 329 | 2010 |
| Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes L Gennari, D Merlotti, R Valenti, E Ceccarelli, M Ruvio, MG Pietrini, ... The Journal of Clinical Endocrinology 97 (5), 1737-1744, 2012 | 305 | 2012 |
| Guidelines for the management of osteoporosis and fragility fractures R Nuti, ML Brandi, G Checchia, O Di Munno, L Dominguez, P Falaschi, ... Internal and emergency medicine 14, 85-102, 2019 | 295 | 2019 |
| Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men L Gennari, D Merlotti, G Martini, S Gonnelli, B Franci, S Campagna, ... The Journal of Clinical Endocrinology & Metabolism 88 (11), 5327-5333, 2003 | 287 | 2003 |
| Obesity and fracture risk S Gonnelli, C Caffarelli, R Nuti Clinical Cases in Mineral and Bone Metabolism 11 (1), 9, 2014 | 238 | 2014 |
| Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia A Palazzuoli, D Silverberg, F Iovine, S Capobianco, G Giannotti, ... American heart journal 152 (6), 1096. e9-1096. e15, 2006 | 232 | 2006 |
| Aromatase activity and bone homeostasis in men L Gennari, R Nuti, JP Bilezikian The Journal of Clinical Endocrinology & Metabolism 89 (12), 5898-5907, 2004 | 226 | 2004 |
| Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome A Palazzuoli, DS Silverberg, F Iovine, A Calabrò, MS Campagna, ... American heart journal 154 (4), 645. e9-645. e15, 2007 | 198 | 2007 |
| Endocrine actions of osteocalcin A Patti, L Gennari, D Merlotti, F Dotta, R Nuti International journal of endocrinology 2013, 2013 | 192 | 2013 |
| Genome-wide association identifies three new susceptibility loci for Paget's disease of bone Nature genetics 43 (7), 685-689, 2011 | 190 | 2011 |
| Comparative effects of teriparatide and risedronate in glucocorticoid‐induced osteoporosis in men: 18‐month results of the EuroGIOPs trial CC Glüer, F Marin, JD Ringe, F Hawkins, R Möricke, N Papaioannu, ... Journal of bone and mineral research 28 (6), 1355-1368, 2013 | 187 | 2013 |
| Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women G Martini, R Valenti, S Giovani, B Franci, S Campagna, R Nuti Bone 28 (1), 113-117, 2001 | 172 | 2001 |
| Osteoporosis and risk of fracture in patients with diabetes: an update A Montagnani, S Gonnelli, M Alessandri, R Nuti Aging clinical and experimental research 23, 84-90, 2011 | 169 | 2011 |
| Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study R Nuti, P Siviero, S Maggi, G Guglielmi, C Caffarelli, G Crepaldi, ... Osteoporosis international 20, 989-998, 2009 | 157 | 2009 |
| Mechanisms of impaired bone strength in type 1 and 2 diabetes D Merlotti, L Gennari, F Dotta, D Lauro, R Nuti Nutrition, Metabolism and Cardiovascular Diseases 20 (9), 683-690, 2010 | 156 | 2010 |
| Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study S Adami, G Isaia, G Luisetto, S Minisola, L Sinigaglia, R Gentilella, ... Journal of Bone and Mineral Research 21 (10), 1565-1570, 2006 | 154 | 2006 |
| Hypertension, left ventricular hypertrophy and chronic kidney disease S Taddei, R Nami, RM Bruno, I Quatrini, R Nuti Heart failure reviews 16, 615-620, 2011 | 150 | 2011 |
| Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study S Kaptoge, LI Benevolenskaya, AK Bhalla, JB Cannata, S Boonen, ... Bone 36 (3), 387-398, 2005 | 144 | 2005 |
| Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study MR McClung, ML O'Donoghue, SE Papapoulos, H Bone, B Langdahl, ... The lancet Diabetes & endocrinology 7 (12), 899-911, 2019 | 140 | 2019 |
